The results indicated that SFPs could improve diabetic symptoms, hyperglycemia, insulin resistance, glucose tolerance, hyperlipemia, organ injury, chronic inflammation and oxidative stress, and SFP-2 showed better regulatory effects on the levels of TC, TG, LDL-C, FFA, TBA, BUN, SOD and MDA. The gene discussed is SOD1; the disease is Hyperglycemia.